“…The use of chitosan [poly-(β-1/4)-2-amino-2-deoxy-Dglucopyranose] has been described in several preclinical studies and tested in tissue bioengineering of bone (Zhao et al, 2002;Kim et al, 2004;Yoshida et al, 2004;Teng et al, 2008;Yuan et al, 2008;Liu et al, 2009;Xianmiao et al, 2009;Li et al, 2010;Mota et al, 2012;Pu et al, 2012;Zhang et al, 2012;Azevedo et al, 2014;Fan et al, 2014;Rodriguez-Vázquez et al, 2015;Vega-Ruiz et al, 2017) neural tissue (Simoes et al, 2011;Meyer et al, 2016;Ghasemi Hamidabadi et al, 2017;Nawrotek et al, 2017;Zhao et al, 2017) and soft tissue (Gobin et al, 2006;Paulo et al, 2009;Tchemtchoua et al, 2011;Udpa et al, 2013;Zou et al, 2017). Chitosan is a copolymer derived from the alkaline deacetylation of chitin and made of N-acetyl-D-glucosamine and D-glucosamine bonds and β bonds in which glucosamine is the main repeating unit in its structure (Rodriguez-Vázquez et al, 2015).…”